A review of dyspnea in acute heart failure syndromes

American Heart Journal

Volumn 160, Issue 2, 2010, Pages 209-214

  West, Ryenn L ^a   Hernandez, Adrian F ^a   O'Connor, Christopher M ^a   Starling, Randall C ^b   Califf, Robert M ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; AGE; ANEMIA; BASELINE DYSPNEA INDEX; BORG SCALE; CHEMORECEPTOR; CONGESTIVE HEART FAILURE; DIAPHRAGM; DISEASE SEVERITY; DYSPNEA; DYSPNEA SEVERITY SCORE; EFFERENT NERVE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LIKERT SCALE; LUNG RECEPTOR; MALNUTRITION; MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MORTALITY; OXYGEN COST DIAGRAM; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RESPIRATION CENTER; REVIEW; SAN DIEGO SHORTNESS OF BREATH QUESTIONNAIRE; SITTING; SUPINE POSITION; TRANSITION DYSPNEA INDEX; UNIVERSITY OF CALIFORNIA SHORTNESS OF BREATH QUESTIONNAIRE; VISUAL ANALOG SCALE;

DYSPNEA; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; PAIN MEASUREMENT; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 77955436904     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.020     Document Type: Review

References (23)

1. Gheorghiade M., Zannad F., and Sopko G. Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968 (Pubitemid 43739494)
2. American Thoracic Society Dyspnea. Mechanisms, assessment, and management: a consensus statement Am J Respir Crit Care Med 159 1999 321 340
3. Manning H.L., and Scwartzstein R.M. Pathophysiology of dyspnea N Engl J Med 333 1995 1547 1552
4. Ambrosino N., and Serradori M. Determining the cause of dyspnoea: linguistic and biological descriptors Chron Respir Dis 3 2006 117 122
5. Parshall M.B., Welsh J.D., and Brockopp D.Y. Reliability and validity of dyspnea sensory quality descriptors in heart failure patients treated in an emergency department Heart Lung 30 2001 57 65
6. Allen L.A., Hernandez A.F., and O'Connor C.M. End points for clinical trials in acute heart failure syndromes J Am Coll Cardiol 53 2009 2248 2258
7. Hajiro T., Nishimura K., and Tsukino M. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease Am J Resp Crit Care Med 158 1998 1185 1189
8. Cullen D.L., and Rodak B. Clinical utility of measures of breathlessness Respir Care 47 2002 986 993
9. Teerlink J.R. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure Am Heart J 145 2003 S26 S33
10. Boni E., Bezzi M., and Carminati L. Expiratory flow limitation is associated with orthopnea and reversed by vasodilators and diuretics in left heart failure Chest 128 2005 1050 1057
11. Jaeschke R., Singer J., and Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415
12. Karras D.J., Sammon M.E., and Terregino C.A. Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327 334
13. Slawsky M.T., Colucci W.S., and Gottlieb S.S. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure Circulation 102 2000 2222 2227
14. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
15. Torre-Amione G., Young J.B., and Colucci W.S. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist in patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 42 2003 140 147
16. Allen L.A., Metra M., and Milo-Cotter O. Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF) J Card Fail 14 2008 777 784
17. Ander D.S., Aisiku I.P., and Ratcliff J.J. Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 10 2004 188 191
18. Kupferberg D.H., Kaplan R.M., and Slymen D.J. Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire J Cardiopulm Rehabil 25 2005 370 377
19. Witek T.J., and Mahler D.A. Minimal important difference of the transition dyspnoea index in a multinational clinical trial Eur Respir J 21 2003 267 272
20. McMurray J.J., and Stewart S. The burden of heart failure Eur Heart J 2 2002 D50 D58
21. Mebazaa A., Pang P.S., and Tavares M. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study Eur Heart J 2009 [Epub ahead of print]
22. Pang P.S., Cleland J.G., and Teerlink J.R. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur Heart J 29 2008 816 824
23. Hernandez A.F., Connor C.M., and Starling R.C. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF) Am Heart J 157 2009 271 277